The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Jasper Therapeutics Inc shares valued at $21,740 were sold by Mahal Jeetinder Singh on Jun 12 ’24. At $24.16 per share, Mahal Jeetinder Singh sold 900 shares. The insider’s holdings dropped to 25,009 shares worth approximately $0.55 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mahal Jeetinder Singh sold 900 shares, netting a total of over 23,792 in proceeds. Following the sale of shares at $26.44 each, the insider now holds 25,009 shares.
Before that, Velan Capital Investment Manag had added 350,000 shares to its account. In a trade valued at $4,532,500, the 10% Owner bought Jasper Therapeutics Inc shares for $12.95 each. Upon closing the transaction, the insider’s holdings increased to 350,000 shares, worth approximately $26.31 million.
As published in their initiating research note from Stifel on June 27, 2024, Jasper Therapeutics Inc [JSPR] has been a Buy and the price target has been revised to $86. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of April 03, 2024, Evercore ISI has initiated its “an Outperform” rating for JSPR. Earlier on March 28, 2024, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for JSPR stock.
Analyzing JSPR Stock Performance
During the last five days, there has been a surge of approximately 5.53%. Over the course of the year, Jasper Therapeutics Inc shares have jumped approximately 180.61%. Shares of the company reached a 52-week high of $31.01 on 04/01/24 and a 52-week low of $6.41 on 01/02/24. A 50-day SMA is recorded $23.09, while a 200-day SMA reached $15.80. Nevertheless, trading volume fell to 86634.0 shares from 95800.0 shares the previous day.
Support And Resistance Levels for Jasper Therapeutics Inc (JSPR)
According to the 24-hour chart, there is a support level at 21.60, which, if violated, would cause prices to drop to 21.00. In the upper region, resistance lies at 23.40. The next price resistance is at 24.60. RSI (Relative Strength Index) is 44.29 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.04, which suggests the price will decrease in the coming days. Percent R is at 49.47%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
